Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel
consisted of an online questionnaire; round that there was an 80% median likelihood that 2 involved an online discussion about the ≥9 additional patients with any safety event BACKGROUND: The landscape for hemoaggregated results from round 1; and round 3 (e.g., thrombotic event, death) per year woul...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academy of Managed Care Pharmacy (AMCP)
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |